The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Machine learning-guided discovery and design of non-hemolytic peptides
Abstract
Reducing hurdles to clinical trials without compromising the therapeutic promises of peptide candidates becomes an essential step in peptide-based drug design. Machine-learning models are cost-effective and time-saving strategies used to predict biological activities from primary sequences. Their limitations lie in the diversity of peptide sequences and biological information within these models. Additional outlier detection methods are needed to set the boundaries for reliable predictions; the applicability domain. Antimicrobial peptides (AMPs) constitute an extensive library of peptides offering promising avenues against antibiotic-resistant infections. Most AMPs present in clinical trials are administrated topically due to their hemolytic toxicity. Here we developed machine learning models and outlier detection methods that ensure robust predictions for the discovery of AMPs and the design of novel peptides with reduced hemolytic activity. Our best models, gradient boosting classifiers, predicted the hemolytic nature from any peptide sequence with 95–97% accuracy. Nearly 70% of AMPs were predicted as hemolytic peptides. Applying multivariate outlier detection models, we found that 273 AMPs (~ 9%) could not be predicted reliably. Our combined approach led to the discovery of 34 high-confidence non-hemolytic natural AMPs, the de novo design of 507 non-hemolytic peptides, and the guidelines for non-hemolytic peptide design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
XGBoost: A Scalable Tree Boosting System
Chen, T., & Guestrin, C. (2016) · Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining · doi:10.1145/2939672.2939785 · Cited by 54,569
A decision-theoretic generalization of on-line learning and an application to boosting
Freund, Y., & Schapire, R. E. (1997) · Journal of Computer and System Sciences · doi:10.1006/jcss.1997.1504 · Cited by 20,466
Nearest neighbor pattern classification
Cover, T., & Hart, P. (1967) · IEEE Transactions on Information Theory · doi:10.1109/tit.1967.1053964 · Cited by 16,936
Hosmer, D. W., Lemeshow, S., & Sturdivant, R. X. (2013) · Wiley Series in Probability and Statistics · doi:10.1002/9781118548387 · Cited by 13,861
Gene selection for cancer classification using support vector machines
Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002) · Machine Learning · doi:10.1023/a:1012487302797 · Cited by 9,954
Liu, F. T., Ting, K. M., & Zhou, Z.-H. (2008) · 2008 Eighth IEEE International Conference on Data Mining · doi:10.1109/icdm.2008.17 · Cited by 6,601
LOF: identifying density-based local outliers
Breunig, M. M., Kriegel, H.-P., Ng, R. T., & Sander, J. (2000) · ACM SIGMOD Record · doi:10.1145/335191.335388 · Cited by 5,207
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
A survey on unsupervised outlier detection in high‐dimensional numerical data
Zimek, A., Schubert, E., & Kriegel, H. (2012) · Statistical Analysis and Data Mining The ASA Data Science Journal · doi:10.1002/sam.11161 · Cited by 864
Research works printed but not linked: 57
- Fosgerau, K. & Hoffmann, T. Peptide therapeutics: current status and future directions. Drug Discov. Today 20, 122–128 (2015). · DOI · Paper page
- Haney, E. F., Straus, S. K. & Hancock, R. E. W. Reassessing the host defense peptide landscape. Front. Chem. 7, 1–22 (2019). · DOI · Paper page
- Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E. & Cotter, P. D. Antifungal peptides as therapeutic agents. Front. Cell. Infect. Microbiol. 10, 105 (2020). · DOI · Paper page
- Nyanguile, O. Peptide antiviral strategies as an alternative to treat lower respiratory viral infections. Front. Immunol. 10, 1366 (2019). · DOI
- Lacerda, A. F., Pelegrini, P. B., de Oliveira, D. M., Vasconcelos, ÉA. R. & Grossi-de-Sá, M. F. Anti-parasitic peptides from arthropods and their application in drug therapy. Front. Microbiol. 7, 1–11 (2016). · DOI
- Windley, M. J. et al. Spider-venom peptides as bioinsecticides. Toxins (Basel) 4, 191–227 (2012). · DOI · Paper page
- Gabernet, G., Müller, A. T., Hiss, J. A. & Schneider, G. Membranolytic anticancer peptides. Medchemcomm 7, 2232–2245 (2016). · DOI
- McGregor, D. Discovering and improving novel peptide therapeutics. Curr. Opin. Pharmacol. 8, 616–619 (2008). · DOI · Paper page
- Lin, Y., Cai, Y., Liu, J., Lin, C. & Liu, X. An advanced approach to identify antimicrobial peptides and their function types for penaeus through machine learning strategies. BMC Bioinform. 20, 1–10 (2019). · DOI · Paper page
- Cardoso, M. H. et al. Computer-aided design of antimicrobial peptides: are we generating effective drug candidates?. Front. Microbiol. 10, 1–15 (2020). · DOI · Paper page
- Speck-Planche, A., Kleandrova, V. V., Ruso, J. M. & Dias Soeiro Cordeiro, M. N. First multitarget chemo-bioinformatic model to enable the discovery of antibacterial peptides against multiple gram-positive pathogens. J. Chem. Inf. Model. 56, 588–598 (2016). · DOI
- Kleandrova, V. V., Ruso, J. M., Speck-Planche, A. & Dias Soeiro Cordeiro, M. N. Enabling the discovery and virtual screening of potent and safe antimicrobial peptides. Simultaneous prediction of antibacterial activity and cytotoxicity. ACS Comb. Sci. 18, 490–498 (2016). · DOI
- Munteanu, C. R. et al. Improvement of epitope prediction using peptide sequence descriptors and machine learning. Int. J. Mol. Sci. 20, 4362 (2019). · doi:10.3390/ijms20184362
- Shoombuatong, W., Schaduangrat, N. & Nantasenamat, C. Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI J. 17, 734–752 (2018).
- Gabernet, G. et al. In silico design and optimization of selective membranolytic anticancer peptides. Sci. Rep. 9, 11282 (2019). · DOI
- Speck-Planche, A. & Cordeiro, M. N. D. S. Speeding up the virtual design and screening of therapeutic peptides, in Multi-Scale Approaches in Drug Discovery. 127–147. (Elsevier, Amsterdam, 2017). · DOI
- Win, T. S. et al. HemoPred: a web server for predicting the hemolytic activity of peptides. Future Med. Chem. 9, 275–291 (2017). · DOI
- Chaudhary, K. et al. A web server and mobile app for computing hemolytic potency of peptides. Sci. Rep. 6, 22843 (2016). · DOI · Paper page
- Kawashima, S., Ogata, H. & Kanehisa, M. AAindex: amino acid index database. Nucleic Acids Res. 27, 368–369 (1999). · DOI · Paper page
- Hasan, M. M. et al. HLPpred-Fuse: improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation. Bioinformatics 36, 3350–3356 (2020). · DOI · Paper page
- Timmons, P. B. & Hewage, C. M. HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks. Sci. Rep. 10, 10869 (2020). · DOI
- Gautam, A. et al. Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res. 42, D444–D449 (2014). · DOI · Paper page
- Jungo, F., Bougueleret, L., Xenarios, I. & Poux, S. The UniProtKB/Swiss-Prot Tox-Prot program: a central hub of integrated venom protein data. Toxicon 60, 551–557 (2012). · DOI · Paper page
- Pirtskhalava, M. et al. DBAASP vol 2: an enhanced database of structure and antimicrobial/cytotoxic activity of natural and synthetic peptides. Nucleic Acids Res. 44, D1104–D1112 (2016). · DOI · Paper page
- Wang, G., Li, X. & Wang, Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 44, D1087–D1093 (2016). · DOI · Paper page
- Tharwat, A. Linear vs. quadratic discriminant analysis classifier: a tutorial. Int. J. Appl. Pattern Recognit. 3, 145 (2016). · DOI · Paper page
- Breiman, L., Friedman, J. H., Stone, C. J. & Olshen, R. A. Classification and Regression Trees. The Wadsworth and Brooks-Cole Statistics-Probability Series Wadsworth Statistics/Probability Series (Taylor & Francis, Abingdon, 1984).
- Breiman, L. Random forests. Mach. Learn. 45, 5–32 (2001). · DOI · Paper page
- Friedman, J. H. Machine. Ann. Stat. 29, 1189–1232 (2001). · DOI · Paper page
- Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
- Johnsson, T. A procedure for stepwise regression analysis. Stat. Pap. 33, 21–29 (1992). · doi:10.1007/bf02925308
- Alin, A. Multicollinearity. Wiley Interdiscip. Rev. Comput. Stat. 2, 370–374 (2010). · DOI · Paper page
- He, Z., Xu, X. & Deng, S. Discovering cluster-based local outliers. Pattern Recognit. Lett. 24, 1641–1650 (2003). · DOI · Paper page
- Peng, Y. & Biao, H. KNN based outlier detection algorithm in large dataset. In 2008 International Workshop on Education Technology and Training & 2008 International Workshop on Geoscience and Remote Sensing, ETT GRS, vol 1, 611–613 (2008).
- Lazarevic, A. & Kumar, V. Feature bagging for outlier detection. In Proceedings of the ACM SIGKDD International Conferenceon Knowledge Discovery and Data Mining, 157–166 (2005). · DOI · Paper page
- Zhao, Y., Nasrullah, Z. & Li, Z. PyOD: a python toolbox for scalable outlier detection. J. Mach. Learn. Res. 20, 1–7 (2019).
- Lee, J. A., Peluffo-Ordóñez, D. H. & Verleysen, M. Multi-scale similarities in stochastic neighbour embedding: reducing dimensionality while preserving both local and global structure. Neurocomputing 169, 246–261 (2015). · DOI
- Kraemer, G., Reichstein, M. & Mahecha, M. D. dimRed and coRanking-unifying dimensionality reduction in R. R J. 10, 342 (2018). · DOI
- Van Der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).
- Moore, M. L. Medicinal chemistry. Ind. Eng. Chem. 43, 577–588 (1951). · doi:10.1021/ie50495a015
- Bartels, E. J. H., Dekker, D. & Amiche, M. Dermaseptins, multifunctional antimicrobial peptides: a review of their pharmacology, effectivity, mechanism of action, and possible future directions. Front. Pharmacol. 10, 1–11 (2019). · DOI
- Zhou, J. G. et al. Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides. Fish Shellfish Immunol. 30, 559–568 (2011). · DOI
- Sitaram, N., Subbalakshmi, C., Krishnakumari, V. & Nagaraj, R. Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin. FEBS Lett. 400, 289–292 (1997). · doi:10.1016/s0014-5793(96)01406-8
- Li, J. et al. Anti-infection peptidomics of amphibian skin. Mol. Cell. Proteomics 6, 882–894 (2007). · DOI · Paper page
- Conlon, J. M. et al. Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis. Dev. Comp. Immunol. 35, 644–649 (2011). · doi:10.1016/j.dci.2011.01.017
- Marani, M. M. et al. Characterization and biological activities of ocellatin peptides from the skin secretion of the frog leptodactylus pustulatus. J. Nat. Prod. 78, 1495–1504 (2015). · doi:10.1021/np500907t
- Zohrab, F., Askarian, S., Jalili, A. & Kazemi Oskuee, R. Biological properties, current applications and potential therapeautic applications of brevinin peptide superfamily. Int. J. Pept. Res. Ther. 25, 39–48 (2019). · DOI
- Lai, R. et al. Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. Peptides 23, 427–435 (2002). · DOI · Paper page
- Zhang, X.-J. et al. Distinctive structural hallmarks and biological activities of the multiple cathelicidin antimicrobial peptides in a primitive teleost fish. J. Immunol. 194, 4974–4987 (2015). · DOI
- Couillault, C. et al. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 5, 488–494 (2004). · DOI · Paper page
- Lim, M.-P., Firdaus-Raih, M. & Nathan, S. Nematode peptides with host-directed anti-inflammatory activity rescue Caenorhabditis elegans from a Burkholderia pseudomallei infection. Front. Microbiol. 7, 1436 (2016).
- Kumar, V., Kumar, R., Agrawal, P., Patiyal, S. & Raghava, G. P. S. A method for predicting hemolytic potency of chemically modified peptides from its structure. Front. Pharmacol. 11, 1–8 (2020). · DOI · Paper page
- Seelig, J. Thermodynamics of lipid-peptide interactions. Biochim. Biophys. Acta Biomembr. 1666, 40–50 (2004). · DOI · Paper page
- Guimarães, C. R. W., Mathiowetz, A. M., Shalaeva, M., Goetz, G. & Liras, S. Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation. J. Chem. Inf. Model. 52, 882–890 (2012). · DOI
- Tropsha, A. Best practices for QSAR model development, validation, and exploitation. Mol. Inform. 29, 476–488 (2010). · DOI · Paper page
- Zheng, S. et al. In silico prediction of hemolytic toxicity on the human erythrocytes for small molecules by machine-learning and genetic algorithm. J. Med. Chem. 63, 6499–6512 (2020). · DOI
- Zheng, S. et al. Quantitative prediction of hemolytic toxicity for small molecules and their potential hemolytic fragments by machine learning and recursive fragmentation methods. J. Chem. Inf. Model. 60, 3231–3245 (2020). · DOI
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Likewise, Plisson et al. 2020 combined the ML algorithm with an outlier detection technique to discover AMPs with non-hemolytic profiles [111].”
MethodDiscovering highly potent antimicrobial peptides with deep generative model HydrAMP
Szymczak, P., Możejko, M., Grzegorzek, T., Jurczak, R., Bauer, M., Neubauer, D., Sikora, K., Michalski, M., Sroka, J., Setny, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36994-z · Cited by 231
Accelerating antibiotic discovery through artificial intelligence
Melo, M. C. R., Maasch, J. R. M. A., & de la Fuente-Nunez, C. (2021) · Communications Biology · doi:10.1038/s42003-021-02586-0 · Cited by 234
Toxicity prediction based on artificial intelligence: A multidisciplinary overview
Pérez Santín, E., Rodríguez Solana, R., González García, M., García Suárez, M. D. M., Blanco Díaz, G. D., Cima Cabal, M. D., Moreno Rojas, J. M., & López Sánchez, J. I. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1516 · Cited by 153
Bajorath, J., Chávez-Hernández, A. L., Duran-Frigola, M., Fernández-de Gortari, E., Gasteiger, J., López-López, E., Maggiora, G. M., Medina-Franco, J. L., Méndez-Lucio, O., Mestres, J., et al. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00661-0 · Cited by 38
Self-citation
Metadata
- Authors
- Plisson, F., Ramírez-Sánchez, O., & Martínez-Hernández, C.
- Venue
- Scientific Reports
- Published
- 2020-10-06
- Volume
- 10
- Issue
- 1
- ISSN
- 2045-2322
- Cited by
- 137
- References
- 11
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Machine learning-guided discovery and design of non-hemolytic peptides. https://app.cochat.ai/papers/10.1038/s41598-020-73644-6
- The paper
- Plisson, F., Ramírez-Sánchez, O., & Martínez-Hernández, C. (2020). Machine learning-guided discovery and design of non-hemolytic peptides. Scientific Reports. https://doi.org/10.1038/s41598-020-73644-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.